Latest News

Samsung Biologics Reports Third Quarter 2021 Financial Results

* Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. * Q3'21 operating profit of KRW 167.4 billion increased 196% compared to Q3'20. * Stable supply, strong operational excellence and a high utilization rate across all plants. * Active investment on expansion, pre-sales ac...

2021-10-26 15:23 2566

The Smartest Park on the Block: How One Company Managed to Survive and Thrive Through the Pandemic

NEW YORK, Oct. 26, 2021 /PRNewswire/ -- As COVID-19 continues to take a toll on the global economy, companies are faced with a variety of problems, among which the most severe challenges are strains on cash flow, disruption of supply chains, and pressure from the prolonged pandemic control. A con...

2021-10-26 14:41 1935

No limits for music: Jasmine Flower gathers global voices

NANJING, China, Oct. 26, 2021 /PRNewswire/ -- Recently, Jiangsu has initiated a Jasmine Flower Folk Song Singing Challenge,organized by Jiangsu Provincial Department of Culture and Tourism, on the province's overseas tourism social media accounts (Facebook, TikTok and Instagram), calling for peop...

2021-10-26 13:34 2472

Xi hails restoration of PRC's rights in UN 50 years ago

BEIJING, Oct. 25, 2021 /PRNewswire/ -- A report from chinadaily.com.cn: President Xi Jinping attended and delivered an important speech at a commemorative meeting marking the 50th anniversary of the restoration ofthe People's Republic of China's lawful seat in the United Nations in Beijing on M...

2021-10-26 09:47 2086

Wuxi, the IoT city light up the world

WUXI, China, Oct. 25, 2021 /PRNewswire/ -- On October 23, the 2021 World Internet of Things (IoT) Wuxi Summit was held, kicking off the 2021 World Internet of Things Expo. Experts from the global IoT industry gathered in Wuxi for infinite possibilities brought about by digital transformation and ...

2021-10-26 08:05 2026

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818

JIAXING, China and BURLINGAME, Calif., Oct. 25, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been approved by the Center for Drug Evaluation (CDE) to initiate clinical trials in pati...

2021-10-26 07:30 2314